Peregrine plunges on bad bavituximab data
This article was originally published in Scrip
Executive Summary
Peregrine Pharmaceuticals clearly is a firm believer in the saying, "If at first you don't succeed, try and try again," because the company intends to try again and again … and again to find an effective drug combination for its cancer therapy bavituximab.